[
    [
        {
            "time": "2023-10-10",
            "original_text": "Form 8.3 - Abbvie Plc- Amendment",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "Amendment",
                    "Abbvie Plc"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Form 8.3 - Abbvie Plc- Amendment",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "Form 8.3 - ABBVIE INC",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "ABBVIE INC"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Form 8.3 - ABBVIE INC",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "AbbVie Stock Falls 3%",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Stock",
                    "Falls",
                    "3%"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie Stock Falls 3%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "Amendment",
                    "ABBVIE INC"
                ],
                "sentiment_score": -0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FORM 8.3 - ABBVIE INC - Amendment",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "Form 8.3 - Abbvie Plc - Amendment",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "Amendment",
                    "Abbvie Plc"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Form 8.3 - Abbvie Plc - Amendment",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        }
    ]
]